Switch to:
More From Other Websites
[Podcast] Earnings season’s busiest week: Watch these companies Apr 20 2015
Ignore These Risks to Gilead at Your Peril Apr 20 2015
Midday Glance: Biotechnology companies Apr 20 2015
Gilead Sciences: Why Nomura Sees Upside in Hepatitis C Apr 20 2015
Banks look cheap, but biotechs frothy Apr 20 2015
Why This Trader Likes Gilead Better Than Biogen Apr 19 2015
Morningstar: Gilead Sciences To Grow Its Hepatitis C Market Apr 18 2015
Megamergers rarely mean megabucks for shareholders Apr 17 2015
This company doubled its Foster City office investment in 4 years Apr 17 2015
Gilead Sciences: Heading For a Hep-C Beat? Apr 17 2015
AbbVie's HCV Treatment Granted Priority Review in Japan - Analyst Blog Apr 16 2015
Will a New Vertex Drug for Cystic Fibrosis Become a Budget Buster? Apr 15 2015
How Gilead Plans to Keep Competitors in Check Apr 14 2015
AbbVie: The Old & the New Apr 14 2015
Five companies that may be looking to buy Ariad Pharmaceuticals Apr 14 2015
J&J cuts guidance as strong dollar hits sales Apr 14 2015
Two Biotech Buyout Candidates Apr 14 2015
J&J Earnings Beat Estimates; Guidance Mixed Apr 14 2015
IMS: US prescription drug spending jumped 13 pct. in 2014 Apr 14 2015
IMS: US prescription drug spending jumped 13 pct. in 2014 Apr 14 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK